Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study

Clinica Chimica Acta

Volumn 451, Issue , 2015, Pages 39-45

  Carrera, Paola ^a   Di Resta, Chiara ^a   Volonteri, Chiara ^b   Castiglioni, Emanuela ^a   Bonfiglio, Silvia ^a   Lazarevic, Dejan ^a   Cittaro, Davide ^a   Stupka, Elia ^a   Ferrari, Maurizio ^a,b   Somaschini, Marco ^a   Magaldi, Rosario ^c   Rinaldi, Matteo ^c   Maffei, Gianfranco ^c   Stronati, Mauro ^c   Tzialla, Chryssoula ^c   Borghesi, Alessandro ^c   Tagliabue, Paolo ^c   Fedeli, Tiziana ^c   Citterio, Marco ^c   Mosca, Fabio ^c   Colnaghi, Mariarosa ^c   Lavizzari, Anna ^c   Agosti, Massimo ^c   Francescato, Gaia ^c   Pomero, Giulia ^c   Dalmazzo, Cristina ^c   Boldrini, Antonio ^c   Scaramuzzo, Rosa ^c   Bertino, Enrico ^c   Borgione, Silvia ^c   Martano, Claudio ^c   Carnielli, Virgilio ^c   Nobile, Stefano ^c   Auriemma, Antonietta ^d   Bellan, Cristina ^d   Carrera, Giuseppe ^c   Zambetti, Chiara ^c   Pucello, Riccardo ^c   Palatta, Sara ^c   more..

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c NONE   (Italy)

^d NONE   (Italy)

Author keywords

Bronchopulmonary dysplasia; Exome sequencing; Genetics

Indexed keywords

C REACTIVE PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; TOLL LIKE RECEPTOR; DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRP GENE; DISEASE PREDISPOSITION; GENE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INDEL MUTATION; LBP GENE; LUNG DYSPLASIA; MMP1 GENE; NEWBORN; NOS2 GENE; PATHOGENESIS; PILOT STUDY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE NUCLEOTIDE VARIANT; START CODON; STOP CODON; TLR GENE; BLOOD; BRONCHOPULMONARY DYSPLASIA; EXOME; GENETIC VARIATION; GENETICS; INFANT; METABOLISM; NEONATAL INTENSIVE CARE UNIT; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; BRONCHOPULMONARY DYSPLASIA; DNA; EXOME; GENETIC VARIATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; PILOT PROJECTS;

EID: 84945473845     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.01.001     Document Type: Article

References (58)

1. Bamshad M.J., Ng S.B., Bigham A.W., Tabor H.K., Emond M.J., Nickerson D.A., et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011, 12:745-755. 10.1038/nrg3031.
2. Merritt T.A., Deming D.D., Boynton B.R. The "new" bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med 2009, 14:345-357. 10.1016/j.siny.2009.08.009.
3. Horbar J.D., Carpenter J.H., Badger G.J., Kenny M.J., Soll R.F., Morrow K.A., et al. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics 2012, 129:1019-1026. 10.1542/peds. 2011-3028.
4. Stoll B.J., Hansen N.I., Bell E.F., Shankaran S., Laptook A.R., Walsh M.C., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126:443-456. 10.1542/peds. 2009-2959.
5. Gien J., Kinsella J.P. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 2011, 23:305-313. 10.1097/MOP.0b013e328346577f.
6. Jobe A.H., Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729. 10.1164/ajrccm.163.7.2011060.
7. Bhandari V., Gruen J.R. The genetics of bronchopulmonary dysplasia. Semin Perinatol 2006, 30:185-191. 10.1053/j.semperi.2006.05.005.
8. Lavoie P.M., Pham C., Jang K.L. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008, 122:479-485. 10.1542/peds. 2007-2313.
9. Shaw G.M., O'Brodovich H.M. Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol 2013, 37:85-93. 10.1053/j.semperi.2013.01.004.
10. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 2010, 11:415-425. 10.1038/nrg2779.
11. Marian A.J. Molecular genetic studies of complex phenotypes. Transl Res 2012, 159:64-79. 10.1016/j.trsl.2011.08.001.
12. Somaschini M., Castiglioni E., Volonteri C., Cursi M., Ferrari M., Carrera P. Genetic predisposing factors to bronchopulmonary dysplasia: preliminary data from a multicentre study. J Matern Fetal Neonatal Med 2012, 25(Suppl. 4):127-130. 10.3109/14767058.2012.714995.
13. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760. 10.1093/bioinformatics/btp324.
14. Robinson J.T., Thorvaldsdóttir H., Winckler W., Guttman M., Lander E.S., Getz G., et al. Integrative genomics viewer. Nat Biotechnol 2011, 29:24-26. 10.1038/nbt.1754.
15. McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010, 20:1297-1303. 10.1101/gr.107524.110.
16. Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L, et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) n.d.;6:80-92. doi:10.4161/fly.19695.
17. Rova M., Haataja R., Marttila R., Ollikainen V., Tammela O., Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004, 13:1095-1104. 10.1093/hmg/ddh132.
18. Ryckman K.K., Dagle J.M., Kelsey K., Momany A.M., Murray J.C. Genetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates. J Perinatol 2012, 32:349-355. 10.1038/jp.2011.104.
19. Hadchouel A., Durrmeyer X., Bouzigon E., Incitti R., Huusko J., Jarreau P.-H., et al. Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med 2011, 184:1164-1170. 10.1164/rccm.201103-0548OC.
20. Kazzi S.N.J., Jacques S.M., Qureshi F., Quasney M.W., Kim U.O., Buhimschi I.A. Tumor necrosis factor-alpha allele lymphotoxin-alpha+250 is associated with the presence and severity of placental inflammation among preterm births. Pediatr Res 2004, 56:94-98. 10.1203/01.PDR.0000130474.12948.A4.
21. Kwinta P., Bik-Multanowski M., Mitkowska Z., Tomasik T., Legutko M., Pietrzyk J.J. Genetic risk factors of bronchopulmonary dysplasia. Pediatr Res 2008, 64:682-688. 10.1203/PDR.0b013e318184edeb.
22. Chen J., Bardes E.E., Aronow B.J., Jegga A.G. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009, 37:W305-W311. 10.1093/nar/gkp427.
23. Snel B. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res 2000, 28:3442-3444. 10.1093/nar/28.18.3442.
24. Alejandre-Alcázar M.A., Kwapiszewska G., Reiss I., Amarie O.V., Marsh L.M., Sevilla-Pérez J., et al. Hyperoxia modulates TGF-beta/BMP signaling in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2007, 292:L537-L549. 10.1152/ajplung.00050.2006.
25. Benjamin J.T., Carver B.J., Plosa E.J., Yamamoto Y., Miller J.D., Liu J.-H., et al. NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression. J Immunol 2010, 185:4896-4903. 10.4049/jimmunol.1001857.
26. Bhattacharya S., Go D., Krenitsky D.L., Huyck H.L., Solleti S.K., Lunger V.A., et al. Genome-wide transcriptional profiling reveals connective tissue mast cell accumulation in bronchopulmonary dysplasia. Am J Respir Crit Care Med 2012, 186:349-358. 10.1164/rccm.201203-0406OC.
27. Bourbon J., Boucherat O., Chailley-Heu B., Delacourt C. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 2005, 57:38R-46R. 10.1203/01.PDR.0000159630.35883.BE.
28. Brasch F., Ochs M., Kahne T., Guttentag S., Schauer-Vukasinovic V., Derrick M., et al. Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung. J Biol Chem 2003, 278:49006-49014. 10.1074/jbc.M306844200.
29. Bühling F., Kouadio M., Chwieralski C.E., Kern U., Hohlfeld J.M., Klemm N., et al. Gene targeting of the cysteine peptidase cathepsin H impairs lung surfactant in mice. PLoS One 2011, 6:e26247. 10.1371/journal.pone.0026247.
30. Chauhan M., Bombell S., McGuire W. Tumour necrosis factor (-308A) polymorphism in very preterm infants with bronchopulmonary dysplasia: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2009, 94:F257-F259. 10.1136/adc.2008.153122.
31. Hikino S., Ohga S., Kinjo T., Kusuda T., Ochiai M., Inoue H., et al. Tracheal aspirate gene expression in preterm newborns and development of bronchopulmonary dysplasia. Pediatr Int 2012, 54:208-214. 10.1111/j.1442-200X.2011.03510.x.
32. Iosef C., Alastalo T.-P., Hou Y., Chen C., Adams E.S., Lyu S.-C., et al. Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarization. Am J Physiol Lung Cell Mol Physiol 2012, 302:L1023-L1036. 10.1152/ajplung.00230.2011.
33. Kho A.T., Bhattacharya S., Tantisira K.G., Carey V.J., Gaedigk R., Leeder J.S., et al. Transcriptomic analysis of human lung development. Am J Respir Crit Care Med 2010, 181:54-63. 10.1164/rccm.200907-1063OC.
34. Londhe V.A., Maisonet T.M., Lopez B., Jeng J.-M., Xiao J., Li C., et al. Conditional deletion of epithelial IKKβ impairs alveolar formation through apoptosis and decreased VEGF expression during early mouse lung morphogenesis. Respir Res 2011, 12:134. 10.1186/1465-9921-12-134.
35. Mallakin A., Kutcher L.W., McDowell S.A., Kong S., Schuster R., Lentsch A.B., et al. Gene expression profiles of Mst1r-deficient mice during nickel-induced acute lung injury. Am J Respir Cell Mol Biol 2006, 34:15-27. 10.1165/rcmb.2005-0093OC.
36. Manar M.H., Brown M.R., Gauthier T.W., Brown L.A.S. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 2004, 24:30-35. 10.1038/sj.jp.7211020.
37. Ray M., Yu S., Sharda D.R., Wilson C.B., Liu Q., Kaushal N., et al. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J Immunol 2010, 185:7309-7316. 10.4049/jimmunol.1000095.
38. Roos A.B., Berg T., Nord M. A relationship between epithelial maturation, bronchopulmonary dysplasia, and chronic obstructive pulmonary disease. Pulm Med 2012, 2012:196194. 10.1155/2012/196194.
39. Sadakata T., Washida M., Morita N., Furuichi T. Tissue distribution of Ca2+-dependent activator protein for secretion family members CAPS1 and CAPS2 in mice. J Histochem Cytochem 2007, 55:301-311. 10.1369/jhc.6A7033.2006.
40. Sampath V., Garland J.S., Le M., Patel A.L., Konduri G.G., Cohen J.D., et al. A TLR5 (g.1174C>T) variant that encodes a stop codon (R392X) is associated with bronchopulmonary dysplasia. Pediatr Pulmonol 2012, 47:460-468. 10.1002/ppul.21568.
41. Ueno T., Linder S., Na C.-L., Rice W.R., Johansson J., Weaver T.E. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004, 279:16178-16184. 10.1074/jbc.M312029200.
42. Wu S., Platteau A., Chen S., McNamara G., Whitsett J., Bancalari E. Conditional overexpression of connective tissue growth factor disrupts postnatal lung development. Am J Respir Cell Mol Biol 2010, 42:552-563. 10.1165/rcmb.2009-0068OC.
43. Zhou Y.-Q., Chen Y.-Q., Fisher J.H., Wang M.-H. Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J Biol Chem 2002, 277:38104-38110. 10.1074/jbc.M206167200.
44. Carraro S., Filippone M., Da Dalt L., Ferraro V., Maretti M., Bressan S., et al. Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev 2013, 89(Suppl. 3):S3-S5. 10.1016/j.earlhumdev.2013.07.015.
45. Herriges M., Morrisey E.E. Lung development: orchestrating the generation and regeneration of a complex organ. Development 2014, 141:502-513. 10.1242/dev.098186.
46. Ramanan V.K., Shen L., Moore J.H., Saykin A.J. Pathway analysis of genomic data: concepts, methods, and prospects for future development. Trends Genet 2012, 28:323-332. 10.1016/j.tig.2012.03.004.
47. Brasch F., Schimanski S., Mühlfeld C., Barlage S., Langmann T., Aslanidis C., et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006, 174:571-580. 10.1164/rccm.200509-1535OC.
48. Fruchter O., Rosengarten D., Goldberg E., Ben-Zvi H., Tor R., Kramer M.R. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction. Clin Respir J 2014, 10.1111/crj.12211.
49. Eckert J.K., Kim Y.J., Kim J.I., Gürtler K., Oh D.-Y., Sur S., et al. The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunity. Immunity 2013, 39:647-660. 10.1016/j.immuni.2013.09.005.
50. Joos L., He J.-Q., Shepherdson M.B., Connett J.E., Anthonisen N.R., Paré P.D., et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002, 11:569-576.
51. Schulzke S.M., Pillow J.J. The management of evolving bronchopulmonary dysplasia. Paediatr Respir Rev 2010, 11:143-148. 10.1016/j.prrv.2009.12.005.
52. Hampl V., Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 2000, 80:1337-1372.
53. D'Alessio F.R., Tsushima K., Aggarwal N.R., Mock J.R., Eto Y., Garibaldi B.T., et al. Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase. J Immunol 2012, 189:2234-2245. 10.4049/jimmunol.1102606.
54. Okamoto T., Gohil K., Finkelstein E.I., Bove P., Akaike T., van der Vliet A. Multiple contributing roles for NOS2 in LPS-induced acute airway inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2004, 286:L198-L209. 10.1152/ajplung.00136.2003.
55. Wang L., Mehta S., Gillis C., Law C., Taneja R. Modulation of neutrophil apoptosis by murine pulmonary microvascular endothelial cell inducible nitric oxide synthase. Biochem Biophys Res Commun 2010, 401:207-212. 10.1016/j.bbrc.2010.09.029.
56. Zeidler P.C., Millecchia L.M., Castranova V. Role of inducible nitric oxide synthase-derived nitric oxide in lipopolysaccharide plus interferon-gamma-induced pulmonary inflammation. Toxicol Appl Pharmacol 2004, 195:45-54. 10.1016/j.taap.2003.10.005.
57. Potter C.F., Kuo N.T., Farver C.F., McMahon J.T., Chang C.H., Agani F.H., et al. Effects of hyperoxia on nitric oxide synthase expression, nitric oxide activity, and lung injury in rat pups. Pediatr Res 1999, 45:8-13. 10.1203/00006450-199901000-00003.
58. Fanos V., Pintus M.C., Lussu M., Atzori L., Noto A., Stronati M., et al. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease. J Matern Fetal Neonatal Med 2014, 27(Suppl. 2):39-45. 10.3109/14767058.2014.955966.